Registry for patients with deep venous obstructions
Ongoing Registry of Deep Venous Reconstructions
This study collects information from patients with deep vein blockages who are getting treated with a specific procedure to see how well it works and if it's safe.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Sex | All |
| Sponsor | Maastricht University Medical Center Academic / other |
| Locations | 1 site (Maastricht) |
| Trial ID | NCT02650453 on ClinicalTrials.gov |
What this trial studies
This ongoing registry collects data on patients suffering from deep venous obstructive disease who are treated using percutaneous transluminal angioplasty (PTA) and stenting, with or without surgical desobstruction of the common femoral vein. The study aims to document the effectiveness and safety of these interventions in patients with significant symptoms and confirmed venous obstruction through imaging techniques. The data is continuously updated in a digital database at a tertiary medical center, allowing for real-time analysis and insights into treatment outcomes.
Who should consider this trial
Good fit: Ideal candidates include patients with venous obstruction in the femoral vein or iliac veins who experience significant symptoms.
Not a fit: Patients who are intolerant to anticoagulant medication or have a life expectancy of less than one year may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could improve treatment strategies and outcomes for patients with deep venous thrombosis.
How similar studies have performed: Previous studies have shown that endovenous reconstructions are safe and effective, indicating a promising approach in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Venous obstruction/occlusion in the femoral vein, common femoral vein, external iliac vein, common iliac vein or inferior vena cava Exclusion Criteria: * Intolerance to anticoagulant medication * A life expectancy \<1 year
Where this trial is running
Maastricht
- Maastricht University Medical Centre — Maastricht, Netherlands (Recruiting)
Study contacts
- Principal investigator: Cees Wittens, MD, PhD — Maastricht University Medical Centre
- Study coordinator: Mark A de Wolf, MD
- Email: m.dewolf@maastrichtuniversity.nl
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.